Fairpointe Capital »

Ovid Therapeutics shares owned by Fairpointe Capital

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Fairpointe Capital from 13F filings

Historical chart of Fairpointe Capital investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Fairpointe Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Fairpointe Capital

Quarter filed Position value Share count Share price at filing
2021-03-31 $288k 72k 4.02
2020-12-31 $281k 122k 2.31
2020-09-30 $699k 122k 5.74
2020-06-30 $934k 127k 7.37
2020-03-31 $422k 142k 2.98
2019-12-31 $588k 142k 4.15
2019-09-30 $327k 101k 3.24
2019-06-30 $187k 101k 1.85
2019-03-31 $179k 101k 1.77
2018-12-31 $99k 41k 2.41